I’ve worked out the radio silence from this company from the us...

I’ve worked out the radio silence from this company from the us clinical trials website

they posted phase 2 to the fda back in September last year to go to phase 3 but it didn’t meet the (QC) criteria of data so the results had been then resubmitted which happened in April/May this year (phase 2 completion was back in 2020 which started in 2017 - the study completion was 2017 and study results 2020) …maybe covid was the culprit here although a bit hard to work out the gap between 2020-2023 so that’s why it’s now ready to go to phase 3 and the news has just come through now regardless

it’s a 12 week treatment period and then 12 week monitoring period looking for wound closure so 6 months per control group (2x p/w for 4 weeks then 1x 8 weeks dosing)

it’s the post adverse effects which make the study trial long at 42 months monitoring it seems

adverse effects seemed fairly same between placebo versus control on my phone so I can’t really go through it well - but it’s not the actual results it’s the way it was posted with numbers that was the issue

can’t find the phase 3 timeline yet but it has to be posted so the timeframe will be up at some point